Standout Papers

Neurofilaments as biomarkers in neurological disorders 2016 2026 2019 2022 1.3k
  1. Neurofilaments as biomarkers in neurological disorders (2018)
    Michael Khalil, Charlotte E. Teunissen et al. Nature Reviews Neurology
  2. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis (2022)
    Kjetil Bjørnevik, Marianna Cortese et al. Science
  3. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis (2017)
    Giulio Disanto, Christian Barro et al. Annals of Neurology
  4. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa (2016)
    Jens Kühle, Christian Barro et al. Clinical Chemistry and Laboratory Medicine (CCLM)
  5. Blood GFAP as an emerging biomarker in brain and spinal cord disorders (2022)
    Ahmed Abdelhak, Matteo Foschi et al. Nature Reviews Neurology
  6. Neurofilament light chain (2015)
    Ching‐Hua Lu, Corrie Macdonald‐Wallis et al. Neurology
  7. Serum neurofilament light levels in normal aging and their association with morphologic brain changes (2020)
    Michael Khalil, Lukas Pirpamer et al. Nature Communications
  8. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response (2019)
    Jens Kühle, Harald Kropshofer et al. Neurology
  9. Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis (2018)
    Christian Barro, Pascal Benkert et al. Brain
  10. Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis (2023)
    Jannis Müller, Alessandro Cagol et al. JAMA Neurology
  11. CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis (2024)
    Johanna Richter, Boris Fehse et al. Med
  12. Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management (2024)
    Mark S. Freedman, Sharmilee Gnanapavan et al. EBioMedicine

Immediate Impact

14 from Science/Nature 66 standout
Sub-graph 1 of 17

Citing Papers

Long COVID science, research and policy
2024 Standout
Mechanisms of long COVID and the path toward therapeutics
2024 Standout
14 intermediate papers

Works of Jens Kühle being referenced

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
2022 StandoutScience
Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19
2020
and 7 more

Author Peers

Author Last Decade Papers Cites
Jens Kühle 6850 6190 4212 399 17.0k
Fredrik Piehl 5484 3994 3602 322 14.6k
Jeffrey A. Cohen 12816 5496 3989 305 22.0k
Yasuto Itoyama 4770 7519 6458 475 20.3k
Gavin Giovannoni 13537 6959 4166 667 25.2k
Axel Petzold 4280 5541 3075 284 13.0k
Friedemann Paul 11742 8500 3044 603 21.2k
Christine Stadelmann 6594 2942 4375 224 16.9k
Wallace W. Tourtellotte 8453 4013 2834 152 15.9k
Jun‐ichi Kira 4406 4731 3060 560 13.4k
Moses Rodriguez 13425 6045 5340 483 26.6k

All Works

Loading papers...

Rankless by CCL
2026